BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15632169)

  • 1. Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells.
    MacAulay K; Blair AS; Hajduch E; Terashima T; Baba O; Sutherland C; Hundal HS
    J Biol Chem; 2005 Mar; 280(10):9509-18. PubMed ID: 15632169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.
    MacAulay K; Hajduch E; Blair AS; Coghlan MP; Smith SA; Hundal HS
    Eur J Biochem; 2003 Sep; 270(18):3829-38. PubMed ID: 12950267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
    Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM
    Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart.
    Mora A; Sakamoto K; McManus EJ; Alessi DR
    FEBS Lett; 2005 Jul; 579(17):3632-8. PubMed ID: 15961082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation.
    Fisher JS; Nolte LA; Kawanaka K; Han DH; Jones TE; Holloszy JO
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1214-21. PubMed ID: 12006350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Carter L; Johnson K; Henry RR
    Diabetes; 2002 Jul; 51(7):2190-8. PubMed ID: 12086949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle.
    Bouskila M; Hirshman MF; Jensen J; Goodyear LJ; Sakamoto K
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E28-35. PubMed ID: 18003720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced glycogenesis is involved in cellular senescence via GSK3/GS modulation.
    Seo YH; Jung HJ; Shin HT; Kim YM; Yim H; Chung HY; Lim IK; Yoon G
    Aging Cell; 2008 Dec; 7(6):894-907. PubMed ID: 18782348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf.
    Cross DA; Alessi DR; Vandenheede JR; McDowell HE; Hundal HS; Cohen P
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):21-6. PubMed ID: 7945242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of insulin resistance in human skeletal muscle cells by downregulation of glycogen synthase protein expression.
    Park KS; Ciaraldi TP; Carter L; Mudaliar S; Nikoulina SE; Webster NJ; Henry RR
    Metabolism; 2000 Aug; 49(8):962-8. PubMed ID: 10954011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase.
    Maile CA; Hingst JR; Mahalingan KK; O'Reilly AO; Cleasby ME; Mickelson JR; McCue ME; Anderson SM; Hurley TD; Wojtaszewski JFP; Piercy RJ
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3388-3398. PubMed ID: 27592162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy.
    Lohi H; Ianzano L; Zhao XC; Chan EM; Turnbull J; Scherer SW; Ackerley CA; Minassian BA
    Hum Mol Genet; 2005 Sep; 14(18):2727-36. PubMed ID: 16115820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
    Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism.
    Kim YB; Peroni OD; Aschenbach WG; Minokoshi Y; Kotani K; Zisman A; Kahn CR; Goodyear LJ; Kahn BB
    Mol Cell Biol; 2005 Nov; 25(21):9713-23. PubMed ID: 16227617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 5'AMP-activated protein kinase in glycogen synthase activity and glucose utilization: insights from patients with McArdle's disease.
    Nielsen JN; Wojtaszewski JF; Haller RG; Hardie DG; Kemp BE; Richter EA; Vissing J
    J Physiol; 2002 Jun; 541(Pt 3):979-89. PubMed ID: 12068056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low birth weight and zygosity status is associated with defective muscle glycogen and glycogen synthase regulation in elderly twins.
    Poulsen P; Wojtaszewski JF; Richter EA; Beck-Nielsen H; Vaag A
    Diabetes; 2007 Nov; 56(11):2710-4. PubMed ID: 17698598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells.
    Hajduch E; Alessi DR; Hemmings BA; Hundal HS
    Diabetes; 1998 Jul; 47(7):1006-13. PubMed ID: 9648821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.